SCHEMBL19991202

SCHEMBL19991202

CCCCCC(=O)OCCC(CC)CC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.66
TSHR P16473 2/20 0.64
CYP3A4 P08684 1/20 0.64
ATM Q13315 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
LMNA P02545 4/20 0.54
DNM1 Q05193 1/20 0.54
ALDH1A1 P00352 1/20 0.54
MAPT P10636 1/20 0.51
PAM P19021 2/20 0.50
KDM4E B2RXH2 1/20 0.49
DUSP3 P51452 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
PRKCA P17252 1/20 0.46
PRKCE Q02156 1/20 0.46
PRKCQ Q04759 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711430 0.91 DGKA (0.65) DGKATSHRCYP3A4ATMTDP1
SCHEMBL6129559 0.91 DGKA (0.65) DGKATSHRCYP3A4ATMTDP1
SCHEMBL20774562 0.91 TSHR (0.68) DGKATSHRCYP3A4ATMTDP1
SCHEMBL6243663 0.89 DGKA (0.67) DGKATSHRCYP3A4ATMTDP1
SCHEMBL25232213 0.89 DGKA (0.66) DGKATSHRCYP3A4ATMTDP1
SCHEMBL648927 0.89 TSHR (0.59) DGKATSHRCYP3A4ATMTDP1
SCHEMBL31620703 0.88 DGKA (0.65) DGKATSHRCYP3A4ATMTDP1
SCHEMBL20774560 0.87 DGKA (0.69) DGKATSHRCYP3A4ATMTDP1
SCHEMBL20786184 0.87 DGKA (0.69) DGKATSHRCYP3A4ATMTDP1
SCHEMBL20775427 0.87 DGKA (0.69) DGKATSHRCYP3A4ATMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317944-A Acyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-07-09 CN disclosed
CN-118234707-A Cyclic lipids and methods of use thereof 雷纳嘉德医疗管理公司 2024-06-21 CN disclosed
CN-118108847-A MRNA mediated immune method 诺华股份有限公司 2024-05-31 CN disclosed
WO-2018063602-A1 PROCESSES FOR PREPARING VINYLIDENE DIMER DERIVATIVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2018-04-05 WO disclosed
US-20180086682-A1 PROCESSES FOR PREPARING VINYLIDENE DIMER DERIVATIVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086682-A1 PROCESSES FOR PREPARING VINYLIDENE DIMER DERIVATIVES ADH1C, ADH1A, ADH5 DGKA 44/4885TSHR 3332/4885CYP3A4 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.